Indian Companies Ramping Up For Follow-On Biologics
This article was originally published in The Pink Sheet Daily
Executive Summary
Indian pharma firms are expected to be active in filing for biosimilar approvals, Ranbaxy exec tells “The Pink Sheet” DAILY